D.C. Mun. Regs. tit. 17, r. 17-10007
Signatories to a collaborative practice agreement shall keep a copy of the agreement on file at their primary places of practice.
The referral of a patient from the physician authorizing the implementation of drug therapy management pursuant to the collaborative practice agreement shall be noted in the patient's medical record and kept on file by the pharmacist.
The patient's documented informed consent shall be retained by the parties to the collaborative practice agreement.
A copy of the collaborative practice agreement, any amendments to the agreement, and the subsequent termination of any such agreement, if applicable, shall be available as follows:
Documentation of activities performed under a collaborative practice agreement or the physician's specific instructions shall be maintained in such a manner that it is accessible to the:
Documentation may be maintained in written or electronic form.
A pharmacist or physician who is a party to the collaborative practice agreement shall have access to the records of the patient who is the recipient of the management of drug therapy.
A patient's records related to the management of drug therapy under a collaborative practice agreement may be maintained in a computerized recordkeeping system which meets all requirements for Federal and State certified electronic health care records.
The handling of all patient records by the pharmacist providing the management of drug therapy must comply with the Health Insurance Portability and Accountability Act of 1996 ( Pub.L. 104-191, 110 Stat. 1936).
The Boards may conduct random audits to ensure compliance with the provisions of the Act and this chapter.
D.C. Mun. Regs. tit. 17, r. 17-10007